We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Zacks.com featured highlights include Universal Health Services, Pinnacle West Capital and Methanex
Read MoreHide Full Article
For Immediate Release
Chicago, IL – February 3, 2026 – Stocks in this week’s article are Universal Health Services, Inc. (UHS - Free Report) , Pinnacle West Capital Corp. (PNW - Free Report) and Methanex Corp. (MEOH - Free Report) .
3 Sales Growth Stocks to Bet On for Robust Returns in 2026
February has just started, and if you haven't yet taken stock of your portfolio and made targeted adjustments aimed at improving risk-adjusted returns, now is the time. Several forces that defined 2025 continue to steer markets — sustained optimism around AI, the Federal Reserve's policy path and persistent geopolitical and tariff-related uncertainties. With signals often conflicting and headlines driving short-term swings, retail investors can benefit most from a disciplined approach — reassessing allocations, tightening risk controls and ensuring the portfolio remains aligned with long-term goals.
Hence, the traditional method of choosing stocks is a good idea. Sales growth provides a more reliable view for evaluating stocks compared with earnings-focused metrics. Stocks like Universal Health Services, Inc., Pinnacle West Capital Corp. and Methanex Corp. are worth considering.
Sales growth is one of the clearest indicators of a company's underlying momentum. Unlike earnings, which can be influenced by accounting choices or short-term cost cuts, revenue reflects real demand for a firm's products and services. Consistent top-line expansion often points to gaining market share, a growing customer base, or successful entry into new markets. Strong revenue trends can also offer an early read on future earnings potential, as higher volumes improve operating leverage and support sustained long-term value creation.
Still, sales figures matter most in context. Benchmarking growth against peers, industry cycles and the broader economic backdrop helps distinguish durable strength from a temporary lift. Companies that can grow through different conditions tend to generate more dependable cash flows, giving management room to reinvest, fund strategic initiatives and protect balance sheet quality without overrelying on debt. Tracking these patterns can help investors spot businesses with resilient competitive advantages and a longer runway for expansion.
3 Stocks with Robust Sales Growth to Buy
King of Prussia, PA-based Universal Health Services owns and operates acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers and radiation oncology centers. UHS' range of services includes general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, pediatric services, pharmacy services and/or behavioral health services.
Universal Health Services' expected sales growth rate for 2026 is 5.2%. UHS carries a Zacks Rank #2 at present.
Headquartered in Phoenix, AZ, Pinnacle West Capital provides electricity services (wholesale or retail) in the state of Arizona through its subsidiaries. PNW is involved in the generation, transmission and distribution of electricity from coal, nuclear, gas, oil and solar.
Pinnacle West Capital's expected sales growth rate for 2026 is 4.6%. PNW currently carries a Zacks Rank #2.
Based in Vancouver, Canada, Methanex is the world's largest supplier of methanol to North America, Asia-Pacific, Europe and Latin America. MEOH purchases methanol from others under contract and on the spot market to meet customer requirements.
MEOH's sales are expected to rise 9.8% in 2026. Methanex carries a Zacks Rank #2 at present.
Why Haven't You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.
Today you can access their live picks without cost or obligation.
Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.
About Screen of the Week
Zacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine. But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use.
Strong Stocks that Should Be in the News
Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has more than doubled the market from 1988 through 2016. Its average gain has been a stellar +25% per year. See these high-potential stocks free >>.
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Zacks.com featured highlights include Universal Health Services, Pinnacle West Capital and Methanex
For Immediate Release
Chicago, IL – February 3, 2026 – Stocks in this week’s article are Universal Health Services, Inc. (UHS - Free Report) , Pinnacle West Capital Corp. (PNW - Free Report) and Methanex Corp. (MEOH - Free Report) .
3 Sales Growth Stocks to Bet On for Robust Returns in 2026
February has just started, and if you haven't yet taken stock of your portfolio and made targeted adjustments aimed at improving risk-adjusted returns, now is the time. Several forces that defined 2025 continue to steer markets — sustained optimism around AI, the Federal Reserve's policy path and persistent geopolitical and tariff-related uncertainties. With signals often conflicting and headlines driving short-term swings, retail investors can benefit most from a disciplined approach — reassessing allocations, tightening risk controls and ensuring the portfolio remains aligned with long-term goals.
Hence, the traditional method of choosing stocks is a good idea. Sales growth provides a more reliable view for evaluating stocks compared with earnings-focused metrics. Stocks like Universal Health Services, Inc., Pinnacle West Capital Corp. and Methanex Corp. are worth considering.
Sales growth is one of the clearest indicators of a company's underlying momentum. Unlike earnings, which can be influenced by accounting choices or short-term cost cuts, revenue reflects real demand for a firm's products and services. Consistent top-line expansion often points to gaining market share, a growing customer base, or successful entry into new markets. Strong revenue trends can also offer an early read on future earnings potential, as higher volumes improve operating leverage and support sustained long-term value creation.
Still, sales figures matter most in context. Benchmarking growth against peers, industry cycles and the broader economic backdrop helps distinguish durable strength from a temporary lift. Companies that can grow through different conditions tend to generate more dependable cash flows, giving management room to reinvest, fund strategic initiatives and protect balance sheet quality without overrelying on debt. Tracking these patterns can help investors spot businesses with resilient competitive advantages and a longer runway for expansion.
3 Stocks with Robust Sales Growth to Buy
King of Prussia, PA-based Universal Health Services owns and operates acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers and radiation oncology centers. UHS' range of services includes general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, pediatric services, pharmacy services and/or behavioral health services.
Universal Health Services' expected sales growth rate for 2026 is 5.2%. UHS carries a Zacks Rank #2 at present.
Headquartered in Phoenix, AZ, Pinnacle West Capital provides electricity services (wholesale or retail) in the state of Arizona through its subsidiaries. PNW is involved in the generation, transmission and distribution of electricity from coal, nuclear, gas, oil and solar.
Pinnacle West Capital's expected sales growth rate for 2026 is 4.6%. PNW currently carries a Zacks Rank #2.
Based in Vancouver, Canada, Methanex is the world's largest supplier of methanol to North America, Asia-Pacific, Europe and Latin America. MEOH purchases methanol from others under contract and on the spot market to meet customer requirements.
MEOH's sales are expected to rise 9.8% in 2026. Methanex carries a Zacks Rank #2 at present.
Why Haven't You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.
Today you can access their live picks without cost or obligation.
See Stocks Free >>
For the rest of this Screen of the Week article please visit Zacks.com at: https://www.zacks.com/stock/news/2826858/3-sales-growth-stocks-to-bet-on-for-robust-returns-in-2026
Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.
About Screen of the Week
Zacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine. But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use.
Strong Stocks that Should Be in the News
Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has more than doubled the market from 1988 through 2016. Its average gain has been a stellar +25% per year. See these high-potential stocks free >>.
Follow us on Twitter: https://www.twitter.com/zacksresearch
Join us on Facebook: https://www.facebook.com/ZacksInvestmentResearch
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Contact: Jim Giaquinto
Company: Zacks.com
Phone: 312-265-9268
Email: pr@zacks.com
Visit: https://www.zacks.com/
Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.